Kurt de Vlam

8.9k citations
172 papers · 3.8k indexed · 2 hit papers · h-index 28
Topics
Spondyloarthritis Studies and Treatments (123 papers)Psoriasis: Treatment and Pathogenesis (83 papers)Rheumatoid Arthritis Research and Therapies (82 papers)

In The Last Decade

Kurt de Vlam

157 papers receiving 3.7k citations

Hit Papers

Infliximab improves signs and symptoms of psoriatic arthr...200520262012201920052019100200300400500

Peers

Kurt de Vlam
Comparison fields: 5 of 105
  • Rheumatology 3.2k
  • Immunology 2.0k
  • Hematology 1.4k
  • Molecular Biology 286
  • Dermatology 211
Replace Jieruo Gu with:
Jieruo Gu China
Feng Huang China
Wayne Tsuji United States
Atul Deodhar United States
Antonio Marchesoni Italy
Ennio Lubrano Italy
Nigil Haroon Canada
R. B. M. Landewé Netherlands
Cédric Lukas France
C. Birbara United States
Kurt de Vlam relative to Jieruo Gu China Jieruo Gu's profile →
Citations per field
00.5×1.6×
Jieruo Gu · 1×
Citations per year

Countries citing papers authored by Kurt de Vlam

Since Specialization
Citations

This map shows the geographic impact of Kurt de Vlam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt de Vlam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt de Vlam more than expected).

Fields of papers citing papers by Kurt de Vlam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt de Vlam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt de Vlam. The network helps show where Kurt de Vlam may publish in the future.

Co-authorship network of co-authors of Kurt de Vlam

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt de Vlam. A scholar is included among the top collaborators of Kurt de Vlam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt de Vlam. Kurt de Vlam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 0
5 1
6 1
7 1
8 12
9 1
10 13
11 14
12 2
13 3
14 20
15 21
16 16
17 11
18 8
19
Agreement between evidence and Belgian rheumatologists' experience on the use of DMARDs for arthritis and/or enthesitis in ankylosing spondylitis
2
20
Treatment with infliximab is associated with "Major clinical response" in psoriatic arthritis patients treated with infliximab: Analysis of two double-blind placebo controlled trials.
2

About Kurt de Vlam

Kurt de Vlam is a scholar working on Rheumatology, Hematology and Immunology, having authored 172 papers that have together received 3.8k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (123 papers), Psoriasis: Treatment and Pathogenesis (83 papers) and Rheumatoid Arthritis Research and Therapies (82 papers). The work is most often cited by research in Rheumatology (3.2k citations), Hematology (1.4k citations) and Immunology (2.0k citations). Kurt de Vlam has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Rik Lories, Frank P. Luyten, Anna Beutler, Cynthia Guzzo, Christian Antoni, Gerald G. Krueger, C. Birbara, Philip J. Mease, L T Dooley and Bin Zhou. Their work appears in journals such as JAMA, The Journal of Immunology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026